Morphine News and Research

Latest Morphine News and Research

Bringing ‘Poogie’ home: Hospice in the time of COVID-19

After she landed in the hospital with a broken hip, Parkinson’s disease and the coronavirus, 84-year-old Dorothy “Poogie” Wyatt Shields made a request of her children: “Bring me home.”

26 May 2020

ED clinicians do not show readiness to offer opioid use disorder therapy

A new study by Yale researchers looking at nearly 400 clinicians at four urban academic emergency departments found that, despite scientific evidence supporting the benefits of buprenorphine for opioid use disorder, just 21% of emergency department clinicians indicated readiness to offer it to patients in need.

11 May 2020

Researchers find a key brain region for controlling binge drinking

A team of National Institutes of Health-funded researchers at the Medical University of South Carolina has found that deactivating a stress-signaling system in a brain area known for motivation and emotion-related behaviors decreases binge drinking.

17 Apr 2020

Tarantula venom could be used as a potent pain reliever

Pain relief has come a long way, with many medicines developed to ease pain and promote comfort. Previous research has shown that venom can be a potent pain reliever. Snake venom has been widely studied as a potential source of pain relievers, especially for chronic and debilitating pain. Now, a team of scientists has found that spider venom, particularly from Tarantulas, could be used as a potent pain reliever for various conditions.

14 Apr 2020

What are the challenges facing palliative care during COVID-19?

The current COVID-19 outbreak affecting 180 countries and territories across six continents is taking its toll on healthcare systems globally. In particular, there is growing pressure on and concern for triage and palliative care departments. Now, researchers from the University of Toronto, Université Laval, Québec, and the University of Ottawa have published a new study titled, “Pandemic palliative care: beyond ventilators and saving lives,” in the latest issue of the journal Canadian Medical Association Journal that looks to address the challenges in providing palliative care during a viral pandemic.

1 Apr 2020

Should you bring mom home from assisted living during the pandemic?

Dr. Alison Webb took her 81-year-old father out of assisted living, to live.

31 Mar 2020

UC researchers identify populations most at risk of overdosing on opiates

Researchers at the University of Cincinnati are helping to identify those most at risk in Ohio of overdosing on opiates.

19 Mar 2020

New step towards the development of non-addictive painkillers

Opioid-containing painkillers are virtually indispensable in clinical practice and are typically used in postoperative patients and patients undergoing cancer treatment.

3 Mar 2020

Opioid prescription for chronic non-cancer pain increased in the last two-and-a-half decades

The number of people with chronic non-cancer pain prescribed an opioid medicine worldwide increased in the last two-and-a-half decades.

25 Feb 2020

Heroin use increasing among American adults

Earlier studies have shown a startling sevenfold increase in illnesses and deaths directly traceable to heroin use in the USA over less than 20 years. Along with this epidemic, HIV and hepatitis infections acquired by injections of drugs have also broken out in large clusters in many places. Yet, the extent of heroin use itself has been neglected. The current study looked at this overlooked area of research.

11 Feb 2020

Re-engineered plant compound reduces morphine-seeking behaviors in mice

The abuse of prescription and illegal opioids, such as morphine and heroin, is a major problem in the U.S., with devastating public health, economic and social consequences.

5 Feb 2020

Roughly half of opioid prescriptions by dentists exceed pain-management guidelines

A new study suggests that roughly half of the opioid prescriptions written by dentists in the United States exceed the three-day supply recommended by federal dental pain-management guidelines.

4 Feb 2020

Opioid dependence produces permanent changes in the brains of rats

Approximately one-quarter of patients who are prescribed opioids for chronic pain misuse them, with five to 10 percent developing an opioid use disorder or addiction.

24 Jan 2020

Majority of people knowingly use fentanyl, UBC research shows

Fentanyl use by people who use drugs has doubled since 2015, and two-thirds of people are aware they've taken it, finds new research out of British Columbia, the Canadian province that has experienced the highest number of illicit drug toxicity deaths as a result of the opioid crisis.

24 Jan 2020

Patients want a ‘good death’ at home, but hospice care can badly strain families

“I’m not anti-hospice at all,” said Joy Johnston, who relocated to New Mexico years ago at age 40 to care for her dying mother.

23 Jan 2020

Controlled-release opioids may lead to endocarditis in injection drug users

A new study from ICES, Lawson Health Research Institute and Western University suggests that injection drug users prescribed controlled-release hydromorphone are three times more likely to develop endocarditis, a serious bacterial heart infection, when compared to those prescribed other opioids.

22 Jan 2020

Most youths do not get timely addiction treatment after opioid overdose

A study of more than 4 million Medicaid claims records during a recent seven-year period concludes that less than a third of the nearly 3,800 U.S. adolescents and young adults who experienced a nonfatal opioid overdose got timely (within 30 days) follow-up addiction treatment to curb or prevent future misuse and reduce the risk of a second overdose.

17 Jan 2020

Family doctors in rural America tackle crisis of addiction and pain

Dr. Angela Gatzke-Plamann didn’t fully grasp her community’s opioid crisis until one desperate patient called on a Friday afternoon in 2016.

10 Jan 2020

FDA’s risk-management program to curb improper opioid prescribing may not have been effective

A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jan 2020